Bio-Techne (TECH) Total Liabilities (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Total Liabilities of $465.3 million in Q1 2026, down 9.07% quarter-over-quarter from $511.7 million in Q4 2025, and down 25.7% on a YoY basis from $626.2 million in Q1 2025.
Bio-Techne (TECH) Total Liabilities (2009 - 2026) Analysis & Trends
Bio-Techne's Total Liabilities history runs 18 years deep, the most recent figure standing at $465.3 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 25.7% year-over-year to $465.3 million; the TTM figure through Mar 2026 stood at $465.3 million (down 25.7% YoY), while the FY2025 annual figure was $639.1 million, up 0.64% from the prior year.
- Total Liabilities was $465.3 million for Q1 2026 at Bio-Techne, down from $511.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $767.2 million in Q4 2023 to a low of $465.3 million in Q1 2026.
- Historically, Total Liabilities has averaged $621.0 million across 5 years, with a median of $599.6 million in 2022.
- The sharpest annual moves came in 2023 and 2026: Total Liabilities soared 43.05% in 2023, then decreased 25.7% in 2026.
- A 5-year view of Total Liabilities shows it stood at $536.3 million in 2022, then jumped by 43.05% to $767.2 million in 2023, then declined by 22.84% to $591.9 million in 2024, then slipped by 13.55% to $511.7 million in 2025, then declined by 9.07% to $465.3 million in 2026.
- The last three Total Liabilities figures came in at $465.3 million (Q1 2026), $511.7 million (Q4 2025), and $560.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 465.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 465.30 Mn |
| Dec 31, 2025 | 511.71 Mn |
| Sep 30, 2025 | 560.33 Mn |
| Jun 30, 2025 | 639.06 Mn |
| Mar 31, 2025 | 626.23 Mn |
| Dec 31, 2024 | 591.93 Mn |
| Sep 30, 2024 | 597.37 Mn |
| Jun 30, 2024 | 635.02 Mn |
| Mar 31, 2024 | 706.80 Mn |
| Dec 31, 2023 | 767.19 Mn |
| Sep 30, 2023 | 757.61 Mn |
| Jun 30, 2023 | 672.18 Mn |
| Mar 31, 2023 | 710.01 Mn |
| Dec 31, 2022 | 536.30 Mn |
| Sep 30, 2022 | 599.57 Mn |
| Jun 30, 2022 | 593.79 Mn |
| Mar 31, 2022 | 586.57 Mn |
| Dec 31, 2021 | 602.32 Mn |
| Sep 30, 2021 | 623.23 Mn |
| Jun 30, 2021 | 691.72 Mn |